LONDON: Africa’s top public health body plans to talk to Merck Talks, though, about getting a supply of the pill for its mollupiravir treatment for Covid-19 pfizer Were more advanced on its Paxlovid drug, it said on Thursday.
“Our priority is to talk only to Pfizer, not Merck, it’s just that Pfizer is moving forward with its engagement. We plan to include both companies equally,” said . John Nekengasong, Director of Africa Centers for Disease Control and Prevention,
“Our priority is to talk only to Pfizer, not Merck, it’s just that Pfizer is moving forward with its engagement. We plan to include both companies equally,” said . John Nekengasong, Director of Africa Centers for Disease Control and Prevention,
,